A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model

Yasunobu Arima1, Daisuke Kamimura1, Toru Atsumi1

  • 1Division of Molecular Neuroimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Elife
|July 21, 2015
PubMed

Insights

Pain can trigger relapse in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). This study reveals how pain activates neural signals leading to inflammation and disease recurrence.

Area of Science:

  • Neuroimmunology
  • Immunology
  • Pathogenesis of autoimmune diseases

Background:

  • Pain is a common symptom in diseases like multiple sclerosis (MS), but its role in disease progression is unclear.
  • Experimental autoimmune encephalomyelitis (EAE) serves as a model to study MS pathogenesis.

Purpose of the Study:

  • To investigate the role of pain in inducing relapse of experimental autoimmune encephalomyelitis (EAE).
  • To elucidate the underlying mechanisms by which pain influences disease relapse in EAE.

Main Methods:

  • Utilized the murine EAE model to study pain-induced disease relapse.
  • Performed mechanistic analysis involving sensory-sympathetic signaling, chemokine-mediated cell accumulation, and immune cell recruitment.
  • Investigated antigen-presentation activity of specific immune cells in the spinal cord.

Main Results:

  • Pain induction was shown to trigger EAE relapse in the EAE model.
  • A sensory-sympathetic signal activates chemokine-mediated accumulation of antigen-presenting cells (MHC class II+CD11b+) at specific spinal cord vessels.
  • This leads to the recruitment of pathogenic immune cells, including CD4+ T cells, resulting in EAE relapse.

Conclusions:

  • Pain can initiate a neural signal that translates into an inflammatory response, specifically at certain blood vessels.
  • This pain-induced inflammation can trigger disease relapse in EAE, suggesting a novel therapeutic target.
  • Targeting the pain-mediated neural pathway offers a potential strategy for managing autoimmune disease relapse.

Related Concept Videos